UK markets closed

Santhera Pharmaceuticals Holding AG (0QN1.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
9.52-0.01 (-0.09%)
At close: 06:03PM BST
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 347.60%
S&P500 52-week change 322.38%
52-week high 313.83
52-week low 30.00
50-day moving average 39.91
200-day moving average 38.98

Share statistics

Avg vol (3-month) 31.3k
Avg vol (10-day) 31.43k
Shares outstanding 56.44M
Implied shares outstanding 6N/A
Float 85.48M
% held by insiders 121.79%
% held by institutions 13.29%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.1:1
Last split date 303 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 52.99%
Operating margin (ttm)71.83%

Management effectiveness

Return on assets (ttm)36.86%
Return on equity (ttm)653.02%

Income statement

Revenue (ttm)103.38M
Revenue per share (ttm)9.14
Quarterly revenue growth (yoy)8,030.60%
Gross profit (ttm)N/A
EBITDA 54.16M
Net income avi to common (ttm)54.78M
Diluted EPS (ttm)-1.62
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)30.37M
Total cash per share (mrq)2.68
Total debt (mrq)21.55M
Total debt/equity (mrq)35.64%
Current ratio (mrq)0.79
Book value per share (mrq)5.34

Cash flow statement

Operating cash flow (ttm)47.62M
Levered free cash flow (ttm)-10.58M